Dr. Sanchayan Mandal, Consultant Medical Oncologist, HCG Cancer Hospital, New Town Kolkata
“Recent advances in oncology are redefining what is possible even in stage 4 metastatic cancers, where the goal was once limited to symptom control. Today, breakthrough approaches such as combination therapy, particularly the integration of immunotherapy with chemotherapy, are demonstrating remarkable outcomes. Backed by emerging clinical evidence, including recently published trials, this strategy is not only improving survival but also delivering rapid and meaningful symptomatic relief. For patients with a high tumor burden, who often present with intense pain and compromised quality of life, this approach is helping shrink tumors faster, reduce suffering, and restore a degree of normalcy that was previously unimaginable.”
“What is truly encouraging is how these scientific advancements are translating into real patient stories. We are seeing individuals with advanced cancers, such as stage 4 lung or head and neck cancers, regaining function and dignity in their daily lives. In one such case, a patient with advanced carcinoma lung stage 4 disease, who is also a skilled mouth organ (flute) player, has been able to resume his passion despite the severity of his condition. This reflects a powerful shift in cancer care, from merely extending life to actively improving how that life is lived. Combination therapy is emerging as a transformative trend, enabling even late-stage patients to achieve disease control, reduced pain, and a meaningful return to the activities that define them.”
Stage 4 Metastatic Cancer Care Is Evolving Beyond Survival Toward Better Quality of Life
